• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在向地方性流行演变过程中的发病率以及与流感的比较。

Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza.

作者信息

Bartha Istvan, Maher Cyrus, Lavrenko Victor, Chen Yi-Pei, Tao Qiqing, di Iulio Julia, Boundy Keith, Kinter Elizabeth, Yeh Wendy, Corti Davide, Telenti Amalio

机构信息

Vir Biotechnology Inc., San Francisco, CA, USA.

出版信息

Commun Med (Lond). 2024 Nov 22;4(1):244. doi: 10.1038/s43856-024-00633-5.

DOI:10.1038/s43856-024-00633-5
PMID:39578575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11584631/
Abstract

BACKGROUND

There are three possible SARS-CoV-2 post-pandemic scenarios: (i) ongoing severity, (ii) influenza-like severity, and (iii) a transition to an endemic disease with lesser morbidity similar to that of other human coronaviruses.

METHODS

To assess a possible evolution of the pandemic under the three scenarios, we use data from the US National Covid Cohort Collaborative, CDC COVID-NET, and CDC Fluview and from the WastewaterSCAN Dashboard. We include influenza disease and treatment response as benchmark. The US National Covid Cohort Collaborative allows the quantification of viral-specific morbidity using electronic health records from 424,165 SARS-CoV-2 cases, 53,846 influenza cases, and 199,971 uninfected control subjects from 2021-2022. Evolution of hospitalization rates is estimated from the correlation between national SARS-CoV-2 and influenza hospitalization data and viral gene copies in wastewater.

RESULTS

Our findings reveal that medically attended SARS-CoV-2 infections exhibit similar morbidity to influenza [indicative of scenario (ii)], but SARS-CoV-2 hospitalization rates are one order of magnitude lower than influenza when considering virus concentration in wastewater [indicative of scenario (iii)]. Moreover, SARS-CoV-2 displays a more favorable response to antiviral therapy.

CONCLUSIONS

Our analysis confirms a rapid decline in SARS-CoV-2 morbidity as it transitions to an endemic state.

摘要

背景

SARS-CoV-2大流行后存在三种可能的情况:(i)持续严重,(ii)类似流感的严重程度,以及(iii)转变为发病率较低的地方性疾病,类似于其他人类冠状病毒。

方法

为了评估这三种情况下大流行可能的演变,我们使用了来自美国国家新冠队列协作组、疾病控制与预防中心(CDC)的COVID-NET以及CDC Fluview的数据,以及废水扫描仪表板的数据。我们将流感疾病和治疗反应作为基准。美国国家新冠队列协作组允许使用2021年至2022年期间424,165例SARS-CoV-2病例、53,846例流感病例和199,971名未感染对照受试者的电子健康记录来量化病毒特异性发病率。住院率的演变是根据全国SARS-CoV-2和流感住院数据与废水中病毒基因拷贝数之间的相关性来估计的。

结果

我们的研究结果表明,就医的SARS-CoV-2感染的发病率与流感相似[表明情况(ii)],但考虑到废水中的病毒浓度时,SARS-CoV-2的住院率比流感低一个数量级[表明情况(iii)]。此外,SARS-CoV-2对抗病毒治疗的反应更有利。

结论

我们的分析证实,SARS-CoV-2向地方性状态转变时发病率迅速下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/ec9da381db0c/43856_2024_633_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/e3b57e61fe3b/43856_2024_633_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/a7fe0bc8b018/43856_2024_633_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/ec9da381db0c/43856_2024_633_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/e3b57e61fe3b/43856_2024_633_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/a7fe0bc8b018/43856_2024_633_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5105/11584631/ec9da381db0c/43856_2024_633_Fig3_HTML.jpg

相似文献

1
Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在向地方性流行演变过程中的发病率以及与流感的比较。
Commun Med (Lond). 2024 Nov 22;4(1):244. doi: 10.1038/s43856-024-00633-5.
2
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.飞沫和气溶胶传播 SARS-CoV-2 的传染性和脱落的异质性。
Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774.
5
Providing Access To Monoclonal Antibody Treatment Of Coronavirus (COVID-19) Patients In Rural And Underserved Areas (Archived)为农村及服务欠缺地区的冠状病毒病(COVID-19)患者提供单克隆抗体治疗(存档)
6
Wastewater surveillance of the most common circulating respiratory viruses in Athens: The impact of COVID-19 on their seasonality.雅典地区最常见呼吸道病毒的污水监测:新冠疫情对其季节性的影响。
Sci Total Environ. 2023 Nov 20;900:166136. doi: 10.1016/j.scitotenv.2023.166136. Epub 2023 Aug 9.
7
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
8
Influenza Infection in Ferrets with SARS-CoV-2 Infection History.感染过 SARS-CoV-2 的雪貂中的流感感染。
Microbiol Spectr. 2022 Dec 21;10(6):e0138622. doi: 10.1128/spectrum.01386-22. Epub 2022 Oct 27.
9
Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.美国一家大型学术医疗中心的呼吸道病毒疾病和结局:2023/2024 年呼吸道病毒季节早期的回顾性观察研究。
Microbiol Spectr. 2024 Oct 3;12(10):e0111624. doi: 10.1128/spectrum.01116-24. Epub 2024 Aug 20.
10
Wastewater monitoring for detection of public health markers during the COVID-19 pandemic: Near-source monitoring of schools in England over an academic year.新冠疫情期间通过污水监测检测公共卫生标志物:英格兰一学年期间学校的近源监测。
PLoS One. 2023 May 30;18(5):e0286259. doi: 10.1371/journal.pone.0286259. eCollection 2023.

引用本文的文献

1
The Role of Gut Microbiota in the Modulation of Pulmonary Immune Response to Viral Infection Through the Gut-Lung Axis.肠道微生物群通过肠-肺轴在调节肺部对病毒感染的免疫反应中的作用。
J Inflamm Res. 2025 Aug 26;18:11755-11781. doi: 10.2147/JIR.S525880. eCollection 2025.

本文引用的文献

1
Human pathogen nucleic acids in wastewater solids from 191 wastewater treatment plants in the United States.美国 191 家污水处理厂污水固体中的人类病原体核酸。
Sci Data. 2024 Oct 17;11(1):1141. doi: 10.1038/s41597-024-03969-8.
2
Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications.尼马瑞韦(nirmatrelvir)-利托那韦(ritonavir)与 COVID-19 死亡率和易发生 COVID-19 并发症患者的住院率。
JAMA Netw Open. 2023 Oct 2;6(10):e2336678. doi: 10.1001/jamanetworkopen.2023.36678.
3
A framework for future national pediatric pandemic respiratory disease severity triage: The HHS pediatric COVID-19 data challenge.
未来国家儿童大流行呼吸道疾病严重程度分级框架:美国卫生与公众服务部儿童新冠病毒病数据挑战
J Clin Transl Sci. 2023 Jul 10;7(1):e175. doi: 10.1017/cts.2023.549. eCollection 2023.
4
Wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties.基于污水的流行病学预测了 COVID-19 导致美国 150 多个县每周新增住院人数。
Nat Commun. 2023 Jul 28;14(1):4548. doi: 10.1038/s41467-023-40305-x.
5
Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations.COVID-19 的急性后期后遗症:理解和应对多系统表现的负担。
Lancet Respir Med. 2023 Aug;11(8):739-754. doi: 10.1016/S2213-2600(23)00239-4. Epub 2023 Jul 17.
6
Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.尼马曲韦联合治疗与新冠病毒感染后综合征风险的关联。
JAMA Intern Med. 2023 Jun 1;183(6):554-564. doi: 10.1001/jamainternmed.2023.0743.
7
Prediction of hospitalisations based on wastewater-based SARS-CoV-2 epidemiology.基于污水的 SARS-CoV-2 流行病学预测住院情况。
Sci Total Environ. 2023 May 15;873:162149. doi: 10.1016/j.scitotenv.2023.162149. Epub 2023 Feb 10.
8
Wastewater surveillance for public health.污水监测与公共卫生。
Science. 2023 Jan 6;379(6627):26-27. doi: 10.1126/science.ade2503. Epub 2023 Jan 5.
9
Relationships between SARS-CoV-2 in Wastewater and COVID-19 Clinical Cases and Hospitalizations, with and without Normalization against Indicators of Human Waste.新冠病毒在废水中的情况与新冠肺炎临床病例及住院情况之间的关系,有无针对人类排泄物指标进行归一化处理。
ACS ES T Water. 2022 Nov 11;2(11):1992-2003. doi: 10.1021/acsestwater.2c00045. Epub 2022 May 26.
10
Acute and postacute sequelae associated with SARS-CoV-2 reinfection.与 SARS-CoV-2 再感染相关的急性和后期后遗症。
Nat Med. 2022 Nov;28(11):2398-2405. doi: 10.1038/s41591-022-02051-3. Epub 2022 Nov 10.